Recalls and outbreaks associated with Salmonella contamination in peanut-containing products have been reported (CDC, 2007; CDC, 2009; CDC, 2012; Christian et al., 2007; Kirk et al., 2004). The peanut industry became very concerned after the initial outbreak and took steps to improve food safety for peanuts and peanut products. These steps included assigning individuals to review the current state of knowledge regarding potential pathogen contamination. Additionally, Good Manufacturing Practices for all segments of the industry were revised (American Peanut Council, 2016) and literature searches were initiated to identify where knowledge and training were needed. It was discovered that very little published information was available on the prevalence of Salmonella on peanuts as well as the times and temperatures needed to adequately inactivate the bacterium during roasting. This led to the approval and funding of two research studies.
Food and Drug Administration rules under the Food Safety Modernization Act (FSMA) require raw peanut handling facilities to report identified hazards, such as Salmonella, to their customers. Facilities that only store or handle peanuts are not required to apply preventive controls for Salmonella. However, notifications must be made up the supply chain until a customer with control capability, such as roasting, is reached. This facility would then be expected to include the control step in their food safety plan. A FSMA requirement, currently on hold, would require the controlling facility to communicate control actions taken back down the supply chain.
This article reviews the research studies commissioned by the American Peanut Council (APC) and related quantitative microbiological risk assessments and factors for decision making that risk managers at peanut and peanut product processing facilities should consider for hazard control measures. Factors considered include not only prevalence and concentration of Salmonella, but also inactivation treatment (roasting), product storage conditions and times, blanching, and amount of peanuts consumed raw. Additionally, what-if scenarios were explored to investigate the impact of varying levels of prevalence, concentration, and percent consumed raw.
Review of Salmonella Research Studies and QMRAs
The first study reviewed in this paper was designed to establish various times and temperatures needed to reduce Salmonella. The inactivation study entitled “Effect of Oil and Dry Roasting Peanuts at Various Temperatures and Times on Survival of Salmonella and Enterococcus faecium” was conducted and published in Peanut Science (Sanders et al., 2014). FDA’s guidance document entitled “Measures to Address the Risk for Contamination by Salmonella Species in Food Containing a Peanut-Derived Product as an Ingredient” states that “manufacturers of foods containing a peanut-derived product as an ingredient obtain peanut-derived product only from suppliers with validated processes in place to adequately reduce the presence of Salmonella spp. (e.g. by 5 logs)” (FDA, 2009).
A set of tables from the roasting inactivation study was made available to the peanut industry summarizing times and temperatures for various log reductions of Salmonella (Sanders et al., 2014) . These tables included data for both small and large runner and Virginia type peanuts, both oil and dry roasted. An example is shown in Table 1. Processors were urged to use the tables as guidance to set up validation studies on their own specific processes for approximating the time and temperature conditions preferable for their desired log reduction (for example, from Table 1, 146°C for 15 minutes for a 5.1 log reduction).
A second research study reviewed was performed to determine the prevalence and concentration of Salmonella on raw shelled runner and Virginia variety peanuts in the United States (Calhoun et al., 2018). A total of 2,506 samples were analyzed over 7 crop years. The prevalence study resulted in 41 positives (1.63%) with concentration levels ranging from below the lower detection limit of 0.003 MPN/g to 2.4 MPN/g. Most samples with detectable Salmonella measured <0.03 MPN/g. The MPN method may underestimate the true numbers of microorganisms present in food due to clumping of cells, especially when the numbers are very low as in this case (Danyluk et al., 2006; Matner et al., 1990). In attempt to obtain enumerative data as close to the true level present as possible, the sample homogenate in this study was blended to promote the breakup of clumped cells (Calhoun et al., 2018). Regardless, the prevalence of Salmonella in raw peanuts is likely of greater significance than the low numbers present. There was a single result of 2.4 MPN/g that was significantly higher than any other result. Another key finding from this study was that the difference between the number of positive whole peanuts and positive split peanuts was statistically significant with splits having greater prevalence (Calhoun et al., 2018). Another study on raw peanut prevalence published in 2013, although confined to the runner variety only, yielded similar results for prevalence and counts (Miksch et al., 2013).
Using data from the American Peanut Council prevalence study, as well as collecting and providing data on other necessary variables, a quantitative microbiological risk assessment (QMRA) was performed (Casulli et al., 2019). Other necessary variables for a QMRA include factors that may contribute to the reduction of the pathogen, in this case, Salmonella. Factors in this QMRA included peanut storage times and treatments (blanching and roasting). Potential raw consumption was also included. Another important variable is the dose-response, the relationship of the amount of Salmonella consumed to illness produced (Casulli et al., 2019). QMRA uses statistics, mathematical models, and information about pathogen prevalence and concentration to simulate the probability of foodborne illness for a given food, hazard, and population of interest.
Although there is no established standard risk measurement, the chance of greater than one illness per year is often referenced. Key results from the QMRA statistical models included that under the current baseline conditions that include the current assumptions of storage conditions, peanut processing conditions, and consumption patterns in the United States, as well as the measured Salmonella prevalence and concentration, the model predicts an 11.9% chance of greater than 1 illness per year from all U.S. peanuts. Statistical modeling showed that if the industry applied conditions for a uniform 4 ± 1 log reduction for dry roasting runner and Virginia peanuts the chance of greater than one illness per year from all U.S. peanuts would increase to approximately 30% (Figure 1) (Casulli et al., 2019). It should be noted that there is some degree of uncertainty associated with any QMRA. This is due to the potential variability in assumptions made for contributing factors as well as variability in measured data. Quantitative microbiological risk assessments are still a valuable tool for identifying and comparing risk management practices.
Risk Management Considerations
Now that risk assessment data is available, the challenge is to use this information to make valid risk management decisions regarding treatment conditions or other controllable factors. It is important to keep in mind that the risk assessment consolidates data from a wide variety of sources to make an estimate of the risks that apply to the entire industry. For example, the model uses variables such as the percentage of facilities applying 5 log reduction roasting, the percentage of facilities oil roasting for 7 log reduction, and an estimate of the number of facilities using unvalidated processes with less than 5 logs reduction (Casulli et al., 2019). Therefore, the baseline results are the calculations based on the proportional combination of these treatments. Similarly, applying the variable of storage times (another factor in the assessment), a range of times were possible based on surveys of storage facilities, so the model used a triangular distribution based on the range, not just one storage time value (Casulli et al., 2019). In this way all the possible variable values were integrated into the calculation. Blanching conditions were also included as a potential reduction factor for the estimated percentage of processors that incorporate this step (Casulli et al., 2019). Although peanuts are rarely consumed raw, the risk due to this consumption was also included in the calculations using an estimate of the percent of peanuts consumed raw (Casulli et al., 2019). So, the statistical modeling software uses the prevalence and concentration data, data from the above described variables, and total consumption data to calculate the estimated illness per year due to consumption of contaminated servings (Casulli et al., 2019).
One should keep in mind that the QMRA consolidates data from a number of processors and storage facilities to gauge the overall risk to the industry. Even though the results of the QMRA do not apply directly to any one specific facility, managers can make logical risk management decisions based on the indications in the data.
Generally, Salmonella reduction occurs during storage. (Casulli et al., 2019). Obviously, longer storage times would be beneficial in reducing the risk from Salmonella. However, processors and warehouse manager’s incentives are to maintain inventory levels for “just-in-time” logistics practices in order to deliver fresh product. Consumer storage times simply vary depending on individual need with the freshness dates of consumer retail units dictating the maximum storage time. One can predict the range of storage times and associated reductions but control measures that increase storage would be counter-productive to the quality of peanut products.
Log reduction achieved from blanching was calculated using previously reported thermal inactivation data (Sanders et al., 2014) and common blanching time and temperature (Casulli et al., 2019). Varying these conditions significantly for risk management purposes would be counterproductive in achieving the function of skin removal. Products using blanched peanuts do so to meet product design requirements for quality.
What-if scenarios were modeled to estimate probability of illness if some of the variables were different than actually measured. This allows risk managers to assess the impact for conditions that they may be able to control or change as well as natural variables (such as prevalence) that may vary from year to year. Table 2 summarizes the results of the what if scenarios (Casulli et al., 2019).
Looking at the table we can make some interesting observations. First, if there happens to be a period of time where prevalence is low, as you would expect, there is a significant reduction in predicted illnesses (Casulli et al., 2019). However, prevalence is not routinely measured and there are limited actions product processors can take to reduce raw peanut prevalence. Good agricultural practices such as use of pathogen free seeds, exclusion of animals from crop fields, sanitary agricultural water, and proper storage and transportation are used to reduce field and harvesting contamination. Chapter 1 of the American Peanut Council Good Management Practices reinforces these practices and can be recommended by processors to their suppliers (American Peanut Council, 2016).
Looking back at the prevalence study it was found that shelled split peanuts had a higher prevalence than whole peanuts (Calhoun et al., 2018). This may be due to the fact that splits are the result of kernels that separate during harvest or processing, or result from damaged kernels, exposing more surface area to the environment for a longer period of time. A potential risk management decision may be to treat production lots of split peanuts at a higher level than production lots of whole peanuts. Removal of damaged kernels using high efficiency sorting equipment could also be an effective measure.
Similar to prevalence, there are few practical controls that peanut product processors can apply to control incoming raw peanut Salmonella concentration. Important to note here, though, is that the result of 2.4 MPN/g is rare. It only happened once in 2506 samples over 7 years of representative sampling (Calhoun et al., 2018). Without that high lot, the predicted risk would be lower. When determining treatment levels risk managers may want to take into consideration that the predicted arithmetic mean number of illnesses per year drops from 14.2 to 3.2 if the rare concentration level does not occur (Casulli et al., 2019), still recognizing that rare spikes in the level of contamination may occur. Their decisions can be based on product design criteria, relative confidence in the supplier, crop year quality, and risk tolerance.
Looking at another important result as indicated in figure 1, the predicted chance of >1 illness per year increases from 11.9% to 30% if the industry were to change from a 5-log reduction to a 4-log reduction for all dry roasted peanuts (Casulli et al., 2019). Risk managers should take note that this is an indicator of significantly higher risk and certainly should be taken into consideration. For example, if there are no compelling product design requirements, a minimum validated 5-log reduction, currently used by most processors, would be lower risk than a 4-log reduction. Of course, product design and additional processing may play an important role in these decisions. An example is found in peanut brittle. Many peanut brittle producers favor a light roast peanut that would likely require less than 5-log roasting conditions for the peanuts. However, the temperature of the caramel matrix used in the process of making brittle would likely be high enough to result in additional log reduction conditions to the surface of the peanuts, the likely location of Salmonella contamination. A process validation study could confirm this.
Processors that have not performed a validation study should consider that by not having data regarding their log reduction they are running with the potential risk of not adequately reducing the presence of Salmonella spp. as recommended in the aforementioned FDA guidance (FDA, 2009).
Another factor to consider is the variability of a process. Log reduction calculations in the APC risk assessment all assumed variability of ± 1 log (there was no published data found on log reduction variability for roasted peanuts) (Casulli et al., 2019). If a processor were to measure and reduce the log reduction variability, the result may be a lower risk level. It is important to note that the measured log reduction is an average. Some nuts in a process will receive a higher log reduction than the average. Other peanuts that receive a lower reduction than the average will be at the highest risk of Salmonella survival. Processors can use oven profile studies to establish variability related to oven performance and relative location of peanuts during conveyance through the roaster. Efforts can be made using this data to reduce the magnitude of the variability as well as apply the greatest possible log reduction cycle consistent with color and flavor objectives.
Looking at raw peanut consumption patterns in Table 2 we see a reduction in the arithmetic mean illnesses per year from consumption of 1% to 0.5% to 0% of 11.0 to 6.9 to 5.4 respectively. It would therefore make logical sense to keep raw consumption as low as possible. Larger shellers are now limiting sales of raw peanuts to retail to help manage this risk. Proper cautionary labeling on retail packages of raw peanuts can also help manage this risk.
Other quantitative microbiological risk assessments that may be of interest to peanut risk managers have been performed on almonds. An almond assessment published in 2006 suggested that treatment with polypropylene oxide (PPO) as well as other treatments were promising toward controlling the disease risk associated with consumption of raw almonds (Danyluk et al., 2006). United States regulations implemented in 2007 require all California-grown almonds sold in North America to be processed with a treatment capable of achieving a minimum 4-log reduction in Salmonella (Almonds grown in California: outgoing quality control requirements, 2007). An assessment published in 2012 established that the regulation is effective in maintaining the risk of salmonellosis from consumption of raw almonds below an arithmetic mean of 1 case/year (Lambertini et. al., 2012). These studies show that treatments other than roasting, such as PPO, can be effective in controlling salmonellosis risk in almonds. However, there is little incentive for application of these treatments to peanuts as peanuts are rarely consumed raw. Processors that wish to sell raw peanuts directly to consumers or at retail stores may want to consider investigating non-roasting treatment methods to reduce the risk to consumers who may buy raw peanuts to cook at home.
Summary and Conclusions
No product is risk free. Even though suggestions have been made in this article regarding risk management decisions, only the managers of a specific facility can make these decisions, taking into consideration data from the studies and QMRA, the type of products made, and the company’s risk tolerance. A company may consider performing a customized risk assessment based on their specific business to make more focused decisions. However, these assessments can be very expensive and time consuming.
One should also always keep in mind the FDA regulation on adulteration (Adulterated Food, 2011). If a product at retail is discovered to be positive for Salmonella, it is considered adulterated and is subject to enforcement actions including recall. A deliberate, well thought-out food safety plan and risk analysis can go a long way to protecting consumers from illness and protecting a company from regulatory action.
Adulterated Food, 21 C.F.R. § 342 (2011).
Almonds grown in California: outgoing quality control requirements. 72 Fed. Reg., 15021-15036. (2007).
American Peanut Council. 2016. Good Management Practices. Available at: https://www.peanutsusa.com/food-safety/good-management-practices.html. Accessed 27 December 2018.
Calhoun, R.S., Post, L. Warren, B. Thompson, S. Bontempo. A.R. 2018. Prevalence and concentration of Salmonella on raw, shelled peanuts in the United States. J. Food Prot. 81: 1755– 1760.
Casulli, K.E., Calhoun, S. and Schaffner. D.W. 2019. Modeling the risk of Salmonellosis from consumption of peanuts in the United States. J. Food Prot. 82: 579– 588.
Centers for Disease Control and Prevention [CDC]. 2007. Multistate outbreak of Salmonella serotype Tennessee infections associated with peanut butter - United States, 2006-2007. MMWR. 56: 521– 524.
Centers for Disease Control and Prevention [CDC]. 2009. Multistate outbreak of Salmonella infections associated with peanut butter and peanut butter-containing products - United States, 2008-2009. MMWR. 58: 1– 6.
Centers for Disease Control and Prevention [CDC]. 2012. Multistate outbreak of Salmonella Bredeney infections linked to peanut butter manufactured by Sunland, Inc. Available at: http://www.cdc.gov/salmonella/bredeney-09-12/index.html. Accessed 25 Oct 2012.
Christian, K.A., Schlegel, J. Ard, L. Mays, E. Curry, P. Davis. M. 2007. Outbreak of Salmonella serotype Thompson associated with boiled peanuts – South Carolina, 2006, 56th Annual Epidemic Intelligence Service Centers for Disease Control and Prevention Conference (page 62), Atlanta, Georgia. Retrieved from https://www.cdc.gov/eis/downloads/2007.EIS.Conference.pdf.
Danyluk, M. D., Harris, L. J. and Schaffner. D.W. 2006. Monte Carlo simulations assessing the risk of salmonellosis from consumption of almonds. J. Food Prot. 69: 1594– 9.
Danyluk, M. D., Jones, T. M. Abd, S. J. Schlitt-Dittrich, F. Jacobs, M. and Harris. L. J. 2006. Prevalence and amounts of Salmonella found on raw California almonds. J. Food Prot. 70: 820– 827.
Kirk, M.D., Little, C.L. Lem, M. Fyfe, M. Genobile, D. Tan, A. Threlfall, J. Paccagenella, A. Lightfoot, D. Lyi, H. McIntyre, L. Ward, L. Brown, D.J. Surnam, S. and Fisher. I.S.T. 2004. An outbreak due to peanuts in their shell caused by Salmonella enterica serotypes Stanley and Newport – sharing molecular information to solve international outbreaks. Epidemiol. Infect. 132: 571– 577.
Lambertini, E., Danyluk, M. D. Schaffner, D. W. Winter, C. K. and Harris. L. J. 2012. Risk of salmonellosis from consumption of almonds in the North American market. Food Res. Int. 45: 1166– 1174.
Matner, R.R., Fox, T.L. Mclver, E.E. and Curiale. M.S. 1990. Efficacy of Petrifilm E. coli count plates for E.coli and Coliform enumeration. J. Food Prot. 53: 145– 150.
Miksch, R.M., Leek, J. Myoda, S. Nguyen, T. Tenney, K. Svidenko, V. Greeson, K. Samadpour. M. Prevalence and counts of Salmonella and enterohemorrhagic Escherichia coli in raw, shelled runner peanuts. J. Food Prot. 76: 1668– 1675.
Sanders, T.H., Calhoun. R.S. 2014. Effect of oil and dry roasting of peanuts at various temperatures and times on survival of Salmonella and Enterococcus faecium. Peanut Science. 41: 65– 71.
U. S. Food and Drug Administration (FDA). 2009. Measures to address the risk for contamination by Salmonella species in food containing a peanut-derived product as an ingredient. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-measures-address-risk-contamination-salmonella-species-food-containing-peanut. Accessed 20 April 2018.
- Technical Consultant, American Peanut Council, Alexandria, VA 22314 [^] *Corresponding author Email: email@example.com